Abstract Body (Do not enter title and authors here): Background: Coronary artery calcification (CAC) is a strong independent predictor of CAD, yet the underlying molecular mechanisms remain incompletely understood. We aimed to identify novel molecular mediators of CAC using a multi-omics approach, with a focus on those proteins likely to have a direct effect on the vasculature. Methods: We conducted a proteome-wide association study in a pooled cohort of CARDIA, MESA, and FHS participants with Olink plasma proteomic profiling and CT-based CAC scoring (n = 6468). We identified proteins independently associated with CAC after adjusting for established CAC risk factors (age, sex, BMI, hypertension, diabetes mellitus, chronic kidney disease, statin use, ethnicity, and smoking status). These proteins were further evaluated for their ability to predict myocardial infarction in an expanded cohort of MESA, FHS, and UK Biobank participants (n=57,198). To prioritize proteins involved in vascular smooth muscle cell (VSMC)-mediated calcification, we identified proteins with differential gene expression in human VSMCs cultured in osteogenic media versus normal media. Causal effects of these proteins were evaluated using Two-sample Mendelian randomization (using inverse variance weighting (IVW), Egger and maximum likelihood) with plasma proteomics GWAS summary statistics as exposures and the largest existing CAC GWAS meta-analysis summary statistics as the outcome. Results: Of 2,805 proteins measured, 365 were independently associated with CAC scores (FDR p<0.05), and enriched in pathways related to inflammatory response, immune cell signaling, ECM organization, and key vascular cell signaling pathways (Fig. 1). Among these, 216 proteins also independently predicted myocardial infarction. Transcriptomic analysis in human VSMCs identified 43 genes upregulated under osteogenic conditions, of which 8 demonstrated evidence of causal effects on CAC via Mendelian Randomization. These proteins are implicated in pathways related to immune cell signaling, bone signaling, and metabolic regulation. Conclusion: Using a multi-omics strategy integrating proteomic, transcriptomic, and genomic data, we identified several novel candidate molecular drivers of CAC with supporting evidence for their roles in myocardial infarction and VSMC osteogenic phenotypic modulation. These findings provide promising avenues for future mechanistic studies in vascular calcification.
Guo, Yugene
( Mass General Brigham
, Somerville
, Massachusetts
, United States
)
Guo, Xiuqing
( The Lundquist Institute at Harbor-UCLA Medical Center
, Torrance
, California
, United States
)
Johnson, Craig
( University of Washington
, Seattle
, Washington
, United States
)
Hou, Lifang
( Northwestern University
, Chicago
, Illinois
, United States
)
Liu, Yongmei
( Wake Forest University School of Medicine
, Durham
, North Carolina
, United States
)
Reiner, Alex
( University of Washington
, Seattle
, Washington
, United States
)
Irvin, Ryan
( University of Alabama at Birmingham
, Birmingham
, Alabama
, United States
)
Tahir, Usman
( Beth Israel Deaconess Medical Ctr
, Boston
, Massachusetts
, United States
)
Boerwinkle, Eric
( UTHealth Houston
, Houston
, Texas
, United States
)
Cruz, Daniel
( Beth Israel Deaconess Medical Ctr
, Boston
, Massachusetts
, United States
)
Fornage, Myriam
( UTHealth Houston
, Houston
, Texas
, United States
)
Lee, Sujin
( Mass General Brigham
, Somerville
, Massachusetts
, United States
)
Franceschini, Nora
( University of North Carolina at Chapel Hill
, Chapel Hill
, North Carolina
, United States
)
Heard-costa, Nancy
( Framingham Heart Study
, Boston
, Massachusetts
, United States
)
Li, Yun
( University of North Carolina at Chapel Hill
, Chapel Hill
, North Carolina
, United States
)
Raffield, Laura
( University of North Carolina at Chapel Hill
, Chapel Hill
, North Carolina
, United States
)
Silverman, Edwin
( Mass General Brigham
, Somerville
, Massachusetts
, United States
)
Budoff, Matthew
( The Lundquist Institute at Harbor-UCLA Medical Center
, Torrance
, California
, United States
)
Gerszten, Robert
( Beth Israel Deaconess Medical Ctr
, Boston
, Massachusetts
, United States
)
Lloyd-jones, Donald
( Boston University Medical Center
, Boston
, Massachusetts
, United States
)
Peyser, Patricia
( University of Michigan
, Ann Arbor
, Michigan
, United States
)
Post, Wendy
( Johns Hopkins University
, Baltimore
, Maryland
, United States
)
Murach, Maria
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Vasan, Ramachandran
( Boston University Medical Center
, Boston
, Massachusetts
, United States
)
Rich, Stephen
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Rotter, Jerome
( The Lundquist Institute at Harbor-UCLA Medical Center
, Torrance
, California
, United States
)
Taylor, Kent
( The Lundquist Institute at Harbor-UCLA Medical Center
, Torrance
, California
, United States
)
De Vries, Paul
( UTHealth Houston
, Houston
, Texas
, United States
)
Miller, Clint
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Malhotra, Rajeev
( Mass General Brigham
, Somerville
, Massachusetts
, United States
)
Singh, Kuldeep
( Mass General Brigham
, Somerville
, Massachusetts
, United States
)
Verdezoto, Jose
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Auguste, Gaelle
( University of Virginia
, Charlottesville
, Virginia
, United States
)
Aguet, Francois
( Broad Institute of MIT and Harvard
, Cambridge
, Massachusetts
, United States
)
Ardlie, Kristin
( Broad Institute of MIT and Harvard
, Cambridge
, Massachusetts
, United States
)
Clish, Clary
( Broad Institute of MIT and Harvard
, Cambridge
, Massachusetts
, United States
)
Author Disclosures:
Yugene Guo:DO NOT have relevant financial relationships
| Xiuqing Guo:DO NOT have relevant financial relationships
| Craig Johnson:DO NOT have relevant financial relationships
| Lifang Hou:No Answer
| Yongmei Liu:No Answer
| Alex Reiner:DO NOT have relevant financial relationships
| Ryan Irvin:No Answer
| Usman Tahir:DO NOT have relevant financial relationships
| Eric Boerwinkle:No Answer
| Daniel Cruz:DO NOT have relevant financial relationships
| Myriam Fornage:DO NOT have relevant financial relationships
| Sujin Lee:DO NOT have relevant financial relationships
| Nora Franceschini:DO have relevant financial relationships
;
Advisor:Vertex:Past (completed)
| Nancy Heard-Costa:DO NOT have relevant financial relationships
| Yun Li:No Answer
| Laura Raffield:DO NOT have relevant financial relationships
| Edwin Silverman:No Answer
| Matthew Budoff:DO have relevant financial relationships
;
Researcher:Lilly:Active (exists now)
; Speaker:Boehringer-Ingleheim:Active (exists now)
; Speaker:Lilly:Active (exists now)
; Speaker:Novo Nordisk:Active (exists now)
; Researcher:Novartis:Active (exists now)
; Researcher:Amgen:Active (exists now)
| Robert Gerszten:No Answer
| Donald Lloyd-Jones:DO have relevant financial relationships
;
Employee:American Heart Association:Active (exists now)
| Patricia Peyser:DO NOT have relevant financial relationships
| Wendy Post:DO NOT have relevant financial relationships
| Maria Murach:DO have relevant financial relationships
;
Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
| Ramachandran Vasan:No Answer
| Stephen Rich:DO have relevant financial relationships
;
Consultant:Westat:Active (exists now)
| Jerome Rotter:DO NOT have relevant financial relationships
| Kent Taylor:DO NOT have relevant financial relationships
| Paul De Vries:DO NOT have relevant financial relationships
| Clint Miller:DO have relevant financial relationships
;
Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
; Advisor:Vascentis:Active (exists now)
| Rajeev Malhotra:DO have relevant financial relationships
;
Consultant:Pharmacosmos:Active (exists now)
; Consultant:Rocket Pharma:Active (exists now)
; Royalties/Patent Beneficiary:CardioText:Active (exists now)
; Royalties/Patent Beneficiary:Up to Date:Active (exists now)
; Research Funding (PI or named investigator):Ledicq Foundation:Active (exists now)
; Research Funding (PI or named investigator):AHA:Active (exists now)
; Research Funding (PI or named investigator):NHLBI:Active (exists now)
; Research Funding (PI or named investigator):Amgen:Active (exists now)
; Royalties/Patent Beneficiary:Keros Therapeutics:Active (exists now)
; Consultant:Epizon Pharma:Active (exists now)
; Consultant:Third Pole:Past (completed)
; Consultant:MyoKardia/BMS:Active (exists now)
; Consultant:Kardigan:Active (exists now)
| Kuldeep Singh:DO NOT have relevant financial relationships
| Jose Verdezoto:No Answer
| Gaelle Auguste:No Answer
| Francois Aguet:No Answer
| Kristin Ardlie:No Answer
| Clary Clish:DO NOT have relevant financial relationships
Abid Rimshah, Puviindran Vijitha, Van Eede Matthijs, Henkelman Mark, Miquerol Lucile, Bruneau Benoit, Hui Chi-chung, Kim Kyoung-han, Oh Yena, Liu Wei Fan, Bakr Marwan, Yin Wen Chi, Zhou Yu-qing, Zhang Xiaoyun, Kim Riyoun, Mo Rong